CCPA hemihydrate

Overview

CCPA (2-Chloro-N6-cyclopentyladenosine) hemihydrate a highly selective A1 adenosine receptors agonist with a K i of 0.4 nM. CCPA hemihydrate inhibits adenylate cyclase with an IC 50 of 33 nM. CCPA hemihydrate exhibits anti-seizure and cardiacprotective activity. CCPA hemihydrate can be used for the research of seizure and myocardial infarction.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Neurological Disease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Adenosine Receptor | Products > Signaling Pathways > Adenylate Cyclase

Product Information

• Catalog No.: HY-103185A
• CAS No.: 1217443-91-8
• Molecular Formula: C15H20ClN5O4.1/2H2O
• Molecular Weight: 378.81
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source